Tuesday, January 20, 2026 | 08:30 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Jagsonpal Pharmaceuticals standalone net profit rises 138.16% in the December 2020 quarter

Capital Market

Sales rise 35.92% to Rs 57.10 crore

Net profit of Jagsonpal Pharmaceuticals rose 138.16% to Rs 5.43 crore in the quarter ended December 2020 as against Rs 2.28 crore during the previous quarter ended December 2019. Sales rose 35.92% to Rs 57.10 crore in the quarter ended December 2020 as against Rs 42.01 crore during the previous quarter ended December 2019. ParticularsQuarter EndedDec. 2020Dec. 2019% Var.Sales57.1042.01 36 OPM %11.376.09 -PBDT6.883.11 121 PBT6.612.85 132 NP5.432.28 138

Powered by Capital Market - Live News

 

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 12 2021 | 4:48 PM IST

Explore News